Zephyrnet Logo

Therma Bright to Begin AcuVid(TM) U.S. Clinical Performance Study with Receipt of IRB Conditional Approval

Date:

The clinical performance study, per U.S. Food & Drug Administration guidance, will being immediately at three (3) U.S.-based clinics.
PlatoAi. Web3 Reimagined. Data Intelligence Amplified.
Click here to access.

Source: https://www.biospace.com/article/therma-bright-to-begin-acuvid-tm-u-s-clinical-performance-study-with-receipt-of-irb-conditional-approval/?s=93

spot_img

Latest Intelligence

spot_img

Chat with us

Hi there! How can I help you?